Area of research
Reproductive Medicine · Physiology
Research interest
Research focused on Cancer research and Hepatocellular carcinoma, with related work in Clinical endpoint, Bispecific antibody, Biomarker. Notable publications include 'Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A...', 'CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway', and 'Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and...'.
CHPF2 as a novel biomarker and ponicidin as a potential therapeutic agent in hepatocellular carcinoma
Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and platinum-resistant recurrent ovarian cancer cohorts.
453 Senaparib maintenance in newly diagnosed advanced ovarian cancer: FLAMES study
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5)
CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway